Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K
The profile of the REVEAL-1 Cohort closely mirrors that of the REMAIN-1 Midpoint and Pivotal Cohorts, with an average age of 50 and a gender distribution of 86% women
While not yet FDA-approved, the results are promising especially for individuals who've hit a plateau with other medications like Semaglutide
follow the guidance provided by your trial team
Healthy skin care routines : sun protection, good moisturization, antioxidants via diet, adequate sleep natural ways to improve skin health without risking invasive procedures